The mitochondrial TSPO ligand Atriol mitigates metabolic-associated steatohepatitis by downregulating CXCL1.
Yuchang LiLiting ChenChantal SottasMahima Chandrakant RaulNrupa Dinesh PatelJanaki Ramulu BijjaS Kaleem AhmedAudrey Kapelanski-LamoureuxAnthoula LazarisPeter MetrakosAlexander ZambidisShefali ChopraMeng LiGo SugaharaTakeshi SaitoVassilios PapadopoulosPublished in: Metabolism: clinical and experimental (2024)
Atriol ameliorates MASH both in vitro and in vivo, demonstrating its potential therapeutic benefits in managing MASH.